Evaluation of Oxidative Stress Parameters in Chronic Obstructive Pulmonary Disease before Medical Treatment

Abstract

[1]  H. Kume,et al.  Airway Smooth Muscle Regulated by Oxidative Stress in COPD , 2023, Antioxidants.

[2]  Luis M. Teran,et al.  Oxidative Stress and Air Pollution: Its Impact on Chronic Respiratory Diseases , 2023, International journal of molecular sciences.

[3]  R. Gagliardo,et al.  Overview of the Mechanisms of Oxidative Stress: Impact in Inflammation of the Airway Diseases , 2022, Antioxidants.

[4]  Simin Jiang,et al.  The role of sulfur compounds in chronic obstructive pulmonary disease , 2022, Frontiers in Molecular Biosciences.

[5]  H. Dailah.  Therapeutic Potential of Small Molecules Targeting Oxidative Stress in the Treatment of Chronic Obstructive Pulmonary Disease (COPD): A Comprehensive Review , 2022, Molecules.

[6]  K. Kotani,et al.  Paraoxonase 1 and Chronic Obstructive Pulmonary Disease: A Meta-Analysis , 2021, Antioxidants.

[7]  L. Rogers,et al.  Oxidative Stress Promotes Corticosteroid Insensitivity in Asthma and COPD , 2021, Antioxidants.

[8]  A. Mangoni,et al.  Systematic Review and Meta-Analysis of the Blood Glutathione Redox State in Chronic Obstructive Pulmonary Disease , 2020, Antioxidants.

[9]  M. Hlavati,et al.  Total Antioxidant Status in Stable Chronic Obstructive Pulmonary Disease , 2020, International journal of chronic obstructive pulmonary disease.

[10]  V. Probst,et al.  NOVEL antioxidant and oxidant biomarkers related to sarcopenia in COPD. , 2020, Heart & lung : the journal of critical care.

[11]  T. H. Nguyen,et al.  Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2020, The Lancet. Respiratory medicine.

[12]  Celalettin Çevik,et al.  Paraoxonase Activity and Phenotype Distribution in Patients with Chronic Obstructive Pulmonary Disease. , 2020, The Eurasian journal of medicine.

[13]  A. Mangoni,et al.  Systemic transsulfuration pathway thiol concentrations in chronic obstructive pulmonary disease patients , 2020, European journal of clinical investigation.

[14]  P. Barnes.  Oxidative stress-based therapeutics in COPD , 2020, Redox biology.

[15]  P. Barnes,et al.  Cellular Senescence as a Mechanism and Target in Chronic Lung Diseases. , 2019, American journal of respiratory and critical care medicine.

[16]  Hikmet Çoban,et al.  Comparison of oxidant/antioxidant balance in COPD and non-COPD smokers. , 2019, Heart & lung : the journal of critical care.

[17]  I. Chattopadhyay,et al.  Oxidative Stress Mechanisms in the Pathogenesis of Environmental Lung Diseases , 2019, Oxidative Stress in Lung Diseases.

[18]  S. Taysı,et al.  Radicals, Oxidative/Nitrosative Stress and Preeclampsia. , 2019, Mini reviews in medicinal chemistry.

[19]  D. Baker,et al.  Senescent cells: an emerging target for diseases of ageing , 2017, Nature Reviews Drug Discovery.

[20]  M. Saeidi,et al.  Alzheimer’s Disease and Paraoxonase 1 (PON1) Gene Polymorphisms , 2017, The open biochemistry journal.

[21]  J. Daniluk,et al.  Dynamic changes of paraoxonase 1 activity towards paroxon and phenyl acetate during coronary artery surgery , 2017, BMC Cardiovascular Disorders.

[22]  A. Arısoy,et al.  The relationships among the levels of oxidative and antioxidative parameters, FEV1 and prolidase activity in COPD , 2017, Redox report : communications in free radical research.

[23]  R. Dixit,et al.  Evaluation of Oxidative Stress and Antioxidant Status in Chronic Obstructive Pulmonary Disease , 2017, Scandinavian journal of immunology.

[24]  P. Pirina,et al.  Circulating biomarkers of oxidative stress in chronic obstructive pulmonary disease: a systematic review , 2016, Respiratory Research.

[25]  O. Erel,et al.  A novel oxidative stress marker in patients with Alzheimer’s disease: dynamic thiol–disulphide homeostasis , 2016, Acta Neuropsychiatrica.

[26]  A. Mangoni,et al.  Plasma protein thiols: an early marker of oxidative stress in asthma and chronic obstructive pulmonary disease , 2016, European journal of clinical investigation.

[27]  F. Yerli̇kaya,et al.  Role of oxidative stress and serum lipid levels in stable chronic obstructive pulmonary disease , 2015, Journal of the Chinese Medical Association : JCMA.

[28]  A. A. Hismiogullari,et al.  Paraoxonase 1 phenotype and paraoxonase activity in asthmatic patients. , 2015, Iranian journal of allergy, asthma, and immunology.

[29]  W. Renner,et al.  Oxidative stress and free radicals in COPD – implications and relevance for treatment , 2014, International journal of chronic obstructive pulmonary disease.

[30]  I. Čepelak,et al.  Paraoxonase 1 Activity in Patients with Chronic Obstructive Pulmonary Disease , 2014, COPD.

[31]  Z. Tabka,et al.  Increased Oxidative Stress and Altered Levels of Nitric Oxide and Peroxynitrite in Tunisian Patients with Chronic Obstructive Pulmonary Disease: Correlation with Disease Severity and Airflow Obstruction , 2014, Biological Trace Element Research.

[32]  G. Sieck,et al.  Cigarette smoke-induced mitochondrial fragmentation and dysfunction in human airway smooth muscle. , 2014, American journal of physiology. Lung cellular and molecular physiology.

[33]  A. Gugliucci,et al.  Paraoxonase 1 in neurological disorders , 2014, Redox report : communications in free radical research.

[34]  P. Kirkham,et al.  Oxidative stress in COPD. , 2013, Chest.

[35]  M. Goulart,et al.  Oxidative Stress as an Underlying Contributor in the Development of Chronic Complications in Diabetes Mellitus , 2013, International journal of molecular sciences.

[36]  Suat Zengin,et al.  An assessment of oxidant/antioxidant status in patients with snake envenomation , 2012, Emergency Medicine Journal.

[37]  M. Goodarzi,et al.  Oxidative Stress in COPD Patients, Smokers, and Non-smokers , 2012, Respiratory Care.

[38]  W. MacNee,et al.  Antioxidant pharmacological therapies for COPD. , 2012, Current opinion in pharmacology.

[39]  H. Jakubowski,et al.  Paraoxonase 1 and homocysteine metabolism , 2012, Amino Acids.

[40]  R. Dullaart,et al.  Increased LCAT activity and hyperglycaemia decrease the antioxidative functionality of HDL , 2012, European journal of clinical investigation.

[41]  K. Kotani,et al.  Paraoxonase 1 in Chronic Kidney Failure , 2012, Journal of lipids.

[42]  A. Stefanović,et al.  Pulmonary function, oxidative stress and inflammatory markers in severe COPD exacerbation. , 2011, Respiratory medicine.

[43]  A. Agarwal,et al.  The role of antioxidant therapy in the treatment of male infertility , 2010, Human fertility.

[44]  M. Cazzola,et al.  Biomarkers of lung damage associated with tobacco smoke in induced sputum. , 2009, Respiratory medicine.

[45]  N. Anwar,et al.  Total Thiols: Biomedical Importance And Their Alteration In Various Disorders , 2009 .

[46]  H. Soran,et al.  Variation in paraoxonase-1 activity and atherosclerosis , 2009, Current opinion in lipidology.

[47]  J. Joven,et al.  The paraoxonases: role in human diseases and methodological difficulties in measurement , 2009, Critical reviews in clinical laboratory sciences.

[48]  G. Jarvik,et al.  Paraoxonase 1 (PON1) status and substrate hydrolysis. , 2009, Toxicology and applied pharmacology.

[49]  A. Kaya,et al.  Increased Oxidant Stress and Decreased Antioxidant Status in Erythrocytes of Rats Fed with Zinc-deficient Diet , 2008, Biological Trace Element Research.

[50]  R. Bloomer.  Decreased blood antioxidant capacity and increased lipid peroxidation in young cigarette smokers compared to nonsmokers: Impact of dietary intake , 2007, Nutrition journal.

[51]  M. Genestra.  Oxyl radicals, redox-sensitive signalling cascades and antioxidants. , 2007, Cellular signalling.

[52]  C. Ferrario,et al.  Allelic Variants of the Human Scavenger Receptor Class B Type 1 and Paraoxonase 1 on Coronary Heart Disease: Genotype–Phenotype Correlations , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[53]  J. Roca,et al.  Oxidative stress and airway inflammation in severe exacerbations of COPD , 2005, Thorax.

[54]  L. Costa,et al.  Modulation of paraoxonase (PON1) activity. , 2005, Biochemical pharmacology.

[55]  Christopher J. Rhodes,et al.  Role of oxygen radicals in DNA damage and cancer incidence , 2004, Molecular and Cellular Biochemistry.

[56]  T. Tsuji,et al.  Cigarette smoke induces senescence in alveolar epithelial cells. , 2004, American journal of respiratory cell and molecular biology.

[57]  P. Chanez,et al.  Does systemic inflammation trigger local exercise-induced oxidative stress in COPD? , 2004, European Respiratory Journal.

[58]  H. Kabuto,et al.  Effects of bisphenol A on the metabolisms of active oxygen species in mouse tissues. , 2003, Environmental Research.

[59]  E. Wouters,et al.  ROS in the local and systemic pathogenesis of COPD. , 2003, Free radical biology & medicine.

[60]  Y. Ho,et al.  Mitochondrial superoxide production in kainate-induced hippocampal damage , 2000, Neuroscience.

[61]  W. MacNee,et al.  Lung glutathione and oxidative stress: implications in cigarette smoke-induced airway disease. , 1999, American journal of physiology. Lung cellular and molecular physiology.

[62]  B. La Du,et al.  Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. , 1999, Free radical biology & medicine.

[63]  W. MacNee,et al.  Prognostic significance of plasma D-dimer levels in patients with lung cancer. , 1997, Thorax.

[64]  Tom Starzl,et al.  THE LANCET , 1992, The Lancet.

[65]  P. Durrington,et al.  Paraoxonase prevents accumulation of lipoperoxides in low‐density lipoprotein , 1991, FEBS letters.

[66]  J. Heffner,et al.  Pulmonary strategies of antioxidant defense. , 1989, The American review of respiratory disease.

[67]  A. Bast,et al.  Oxidative Stress in Chronic Obstructive Pulmonary Disease , 2019, Oxidative Stress in Lung Diseases.

[68]  G. Münch,et al.  Chronic Inflammation Alters Production and Release of Glutathione and Related Thiols in Human U373 Astroglial Cells , 2012, Cellular and Molecular Neurobiology.

[69]  R. Tkacova,et al.  The association between oxidative stress and obstructive lung impairment in patients with COPD. , 2007, Physiological research.

[70]  W. Dröge.  Free radicals in the physiological control of cell function. , 2002, Physiological reviews.